The results of mechanistic studies support that metabolic reprogramming, orchestrated by cAMP, mTOR, and AMPK dysregulation, plays an important role in the pathogenesis of ADPKD. The gene discussed is MTOR; the disease is autosomal dominant polycystic kidney disease.